Stockscreener 앱 받기
2.54
3.05%
-0.08
시간 외 거래:
2.52
-0.02
-0.79%
전일 마감가:
$2.62
열려 있는:
$2.61
하루 거래량:
65,445
Relative Volume:
1.55
시가총액:
$27.09M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+22.23%
1개월 성능:
-23.26%
6개월 성능:
-55.44%
1년 성능:
-45.02%
1일 변동 폭
$2.3976
$2.65
1주일 범위
$2.02
$2.99
52주 변동 폭
$1.7101
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
명칭
Serina Therapeutics Inc
전화
(256) 327-9630
주소
601 GENOME WAY, HUNTSVILLE
SER을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
2.54 | 27.94M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-14 | 개시 | H.C. Wainwright | Buy |
Serina Therapeutics Inc 주식(SER)의 최신 뉴스
Serina Therapeutics CSO Moreadith sells $34,953 in shares By Investing.com - Investing.com Canada
Buybacks Report: How supply chain issues affect Serina Therapeutics Inc. stockQuarterly Profit Review & Technical Pattern Based Buy Signals - ulpravda.ru
Will Serina Therapeutics Inc. stock continue dividend increasesPortfolio Risk Report & Long Hold Capital Preservation Tips - ulpravda.ru
Why Serina Therapeutics Inc. stock attracts global investorsWeekly Trade Review & AI Forecast for Swing Trade Picks - ulpravda.ru
Is Serina Therapeutics Inc. (2BO) stock good for long term investingJuly 2025 Opening Moves & Capital Efficiency Focused Strategies - ulpravda.ru
How supply chain issues affect Serina Therapeutics Inc. stockTrade Performance Summary & Weekly Return Optimization Alerts - ulpravda.ru
Serina Therapeutics, Inc. Common Stock (NYSE:SER) Stock Quote - FinancialContent
Forecast Cut: How supply chain issues affect Serina Therapeutics Inc. stock2025 Momentum Check & Fast Gaining Stock Reports - ulpravda.ru
Will Serina Therapeutics Inc. (2BO) stock split increase liquiditySwing Trade & Intraday High Probability Alerts - ulpravda.ru
Can Serina Therapeutics Inc. (2BO) stock sustain breakout momentumTrade Signal Summary & Technical Confirmation Trade Alerts - ulpravda.ru
Is Serina Therapeutics Inc. stock gaining market shareMarket Risk Summary & Daily Risk Controlled Trade Plans - ulpravda.ru
What is the fair value of Serina Therapeutics Inc. stock now2026 world cup usa national team third place match top scorers high defensive line winner prediction insights - ulpravda.ru
Breakout Zone: Is Bolt Biotherapeutics Inc stock vulnerable to regulatory risksTrade Entry Report & Expert-Curated Trade Recommendations - moha.gov.vn
Growth Value: Why Serina Therapeutics Inc stock attracts global investorsWeekly Market Report & Consistent Income Trade Recommendations - moha.gov.vn
Published on: 2025-12-31 12:01:21 - bollywoodhelpline.com
Trade Recap: Can Serina Therapeutics Inc 2BO stock sustain breakout momentumQuarterly Market Summary & Accurate Technical Buy Alerts - moha.gov.vn
Moreadith of Serina Therapeutics sells shares worth $15,167 By Investing.com - Investing.com India
Moreadith of Serina Therapeutics sells shares worth $15,167 - Investing.com
Serina Therapeutics CSO Sells Shares - TradingView — Track All Markets
Serina Therapeutics (SER) Chief Scientific Officer option exercise and share sale - Stock Titan
Aug Sectors: Why Serina Therapeutics Inc. stock is considered a top pickIPO Watch & Safe Capital Growth Plans - Улправда
Will Serina Therapeutics Inc. stock top growth indexes2025 Fundamental Recap & Community Verified Trade Alerts - Улправда
Why Serina Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Short Interest & Community Trade Idea Sharing - Улправда
Ideas Watch: Why Serina Therapeutics Inc. stock attracts global investors2025 Price Action Summary & Long-Term Capital Growth Ideas - moha.gov.vn
Is Serina Therapeutics Inc. stock cheap at current valuationJuly 2025 Volume & Short-Term Trading Alerts - Улправда
Will Serina Therapeutics Inc. stock deliver better than expected guidanceWall Street Watch & AI Powered Market Trend Analysis - DonanımHaber
Will Serina Therapeutics Inc. (2BO) stock sustain uptrend momentum2025 Stock Rankings & AI Forecast Swing Trade Picks - DonanımHaber
Why Serina Therapeutics Inc. stock appeals to dividend seekers2025 Earnings Surprises & Low Risk Investment Opportunities - Улправда
Aug Fed Impact: Will Serina Therapeutics Inc. stock enhance shareholder valueEarnings Risk Summary & Weekly High Potential Alerts - DonanımHaber
Options Flow: Why Serina Therapeutics Inc. stock is favored by top institutionsIPO Watch & Advanced Swing Trade Entry Alerts - ulpravda.ru
Why Serina Therapeutics Inc. stock is favored by top institutionsSell Signal & Reliable Intraday Trade Alerts - Улправда
Why Serina Therapeutics Inc. stock is considered a top pick2025 Key Lessons & High Accuracy Trade Signal Alerts - Улправда
Serina Therapeutics (SER) CSO sells 3,227 shares after option exercise - Stock Titan
Officer Moreadith Sells 3,227 ($9.6K) Of Serina Therapeutics Inc [SER] - TradingView — Track All Markets
Serina Therapeutics (SER) CSO reports 1,700-share option-related trades filing - Stock Titan
Serina Therapeutics Earnings Notes - Trefis
Serina Therapeutics CSO Moreadith sells $11,519 in stock By Investing.com - Investing.com South Africa
Serina Therapeutics CSO Moreadith sells $11,519 in stock - Investing.com
Officer Moreadith Sells 3,555 ($11.5K) Of Serina Therapeutics Inc [SER] - TradingView — Track All Markets
Serina Therapeutics (SER) Chief Scientific Officer reports 3,555-share option exercise and sale - Stock Titan
Serina Therapeutics Holds 2025 Annual Stockholders Meeting - MSN
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry - The Manila Times
Serina Therapeutics (SER) chief scientific officer reports stock option trades - Stock Titan
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program - The Manila Times
Serina Therapeutics (NYSE American: SER) responds to FDA clinical hold, targets Q1 2026 SER-252 Phase 1b start - Stock Titan
Serina Therapeutics Submits Response to FDA for SER-252 Program - TradingView — Track All Markets
Serina Therapeutics (NYSE: SER) files complete FDA hold response for SER-252 Parkinson's program - Stock Titan
Is Serina Therapeutics Inc. stock a defensive play amid uncertaintyWall Street Watch & Verified Momentum Watchlists - Newser
Will Serina Therapeutics Inc. stock sustain bullish trend into 2025Earnings Miss & Fast Gain Stock Trading Tips - Newser
How strong is Serina Therapeutics Inc. stock earnings growthJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser
How Serina Therapeutics Inc. stock moves in volatile trading sessionsWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
Serina Therapeutics Inc (SER) 재무 분석
Serina Therapeutics Inc (SER)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.90%
자본화:
|
볼륨(24시간):